Skip to content


VIC aims to advance research initiatives efficiently from discovery through the preclinical stage to early clinical testing to enable successful product development by an industry or a non-profit partner.

There are now 9 novel medical products under development at VIC targeting specific cancers, infectious and immune mediated diseases including mesothelioma, Q fever and type 1 diabetes. These products are broadly applicable and include devices, cell therapies and the repurposing of immunomodulatory small molecules and the invention of biologics.

The model encompasses: